Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating rheumatic and rheumatoid diseases and its preparation process

A rheumatoid and composition technology is applied in the treatment of rheumatism, the preparation process of the pharmaceutical composition, and the field of pharmaceutical compositions for rheumatoid diseases, which can solve the problems of staying, unable to relieve pain, and many side effects.

Inactive Publication Date: 2008-11-19
兰州和盛堂制药股份有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, most of the clinical analgesic and anti-inflammatory treatments are based on chemical drugs. Western medicines such as "aspirin", "butazone", and "ibuprofen" can only relieve symptoms and reduce pain, but they have many side effects and cause pain. Patients bring other pains and burdens, while most domestic technologies are still in the stage of plasters and lotions, which cannot fundamentally relieve pain and cure diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating rheumatic and rheumatoid diseases and its preparation process
  • Pharmaceutical composition for treating rheumatic and rheumatoid diseases and its preparation process
  • Pharmaceutical composition for treating rheumatic and rheumatoid diseases and its preparation process

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0124] Embodiment 1: the preparation of pharmaceutical granule of the present invention

[0125] 1. Formula (by weight percentage)

[0126]Ephedra 10%, Juniper 15%, Salvia 10%, Astragalus 10%

[0127] Cypress branch 15%, Artemisia grandis 20%, Rhododendron 20%

[0128] 2. Process

[0129] ① Take the four flavors of Juniper, Rhododendron lanceolata, Artemisia grandis and Cypress branch, add 10 times the amount of water, extract the volatile oil by steam distillation, and clathrate the volatile oil with β-cyclodextrin in a water bath at 45°C. Dry and pulverize; extract the medicinal residue and filtrate of volatile oil and keep it for later use;

[0130] ②Extract Salvia miltiorrhiza with 95% ethanol, recover the ethanol in the extract, filter and concentrate to obtain a thick paste;

[0131] ③Decoct the ephedra and astragalus with 10 times the amount of water for 3 times, 1 hour each time, combine the decoction, let it stand, remove the precipitate, filter, and concentrate t...

Embodiment 2

[0135] Embodiment 2: the preparation of pharmaceutical tablet of the present invention

[0136] 1. Formula (by weight percentage)

[0137] Ephedra 20%, Juniper 20%, Salvia 15%, Astragalus 5%

[0138] Cypress branch 20%, Artemisia grandis 10%, Rhododendron 10%

[0139] 2. Process

[0140] ① Take the four flavors of Juniper, Rhododendron lanceolata, Artemisia grandis and Cypress branch, add 10 times the amount of water, extract the volatile oil by steam distillation, and clathrate the volatile oil with β-cyclodextrin in a water bath at 45°C. Dry and pulverize; extract the medicinal residue and filtrate of volatile oil and keep it for later use;

[0141] ②Extract Salvia miltiorrhiza with 95% ethanol, recover the ethanol in the extract, filter and concentrate to obtain a thick paste;

[0142] ③Decoct the ephedra and astragalus with 10 times the amount of water for 3 times, 1 hour each time, combine the decoction, let it stand, remove the precipitate, filter, and concentrate to...

Embodiment 3

[0146] Embodiment 3: the preparation of medicine capsule of the present invention

[0147] 1. Formula (by weight percentage)

[0148] Ephedra 15%, Juniper 10%, Salvia 5%, Astragalus 15%

[0149] Cypress branch 20%, Artemisia grandis 20%, Rhododendron 15%

[0150] 2. Process

[0151] ① Take the four flavors of Juniper, Rhododendron lanceolata, Artemisia grandis and Cypress branch, add 10 times the amount of water, extract the volatile oil by steam distillation, and clathrate the volatile oil with β-cyclodextrin in a water bath at 45°C. Dry and pulverize; extract the medicinal residue and filtrate of volatile oil and keep it for later use;

[0152] ②Extract Salvia miltiorrhiza with 95% ethanol, recover the ethanol in the extract, filter and concentrate to obtain a thick paste;

[0153] ③Decoct the ephedra and astragalus with 10 times the amount of water for 3 times, 1 hour each time, combine the decoction, let it stand, remove the precipitate, filter, and concentrate to obta...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating rheumatic and rheumatoid diseases and its preparation process, wherein the medicinal composition is obtained through mixing Chinese ephedra, common juniper, Myricaria laxiflora, Artemisia sieversiana Willd and fragrant rhododendron leaf with root of red rooted saliva and astragalus root.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, relates to a pharmaceutical composition for treating rheumatism and rheumatoid diseases, and also relates to a preparation process of the pharmaceutical composition. Background technique [0002] Rheumatism and rheumatoid arthritis are autoimmune diseases mainly characterized by chronic inflammation of the joints. It is also one of the most difficult diseases to cure in the world. The pathogenesis is still unclear. According to the survey, it is preliminarily determined that there are more than 3.6 million patients with this disease. At present, most of the clinical analgesic and anti-inflammatory treatments are based on chemical drugs. Western medicines such as "aspirin", "butazone", and "ibuprofen" can only relieve symptoms and reduce pain, but they have many side effects and cause pain. Patients bring other pains and burdens, while most domestic technologies are still in the stage ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/17A61K36/14A61K36/53A61K36/481A61K36/45A61K9/20A61K9/48A61P29/00A61P19/02
Inventor 张喜民连珠田薇王建红张训凯邓科雯任一杰刘静何霞南建理窦霞
Owner 兰州和盛堂制药股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com